𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of patients with cisplatin-refractory testicular germ-cell cancer

✍ Scribed by Carsten Bokemeyer; Christian Kollmannsberger; Andreas Harstrick; Jörg Beyer; Arthur Gerl; Jochen Casper; Bernd Metzner; Jörg T. Hartmann; C. Clemm; Hans-Joachim Schmoll; Lothar Kanz


Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
78 KB
Volume
83
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


With the use of cisplatin-based combination chemotherapy, metastatic testicular germ-cell tumors can be cured in 70% to 80% of patients. The combination of cisplatin, etoposide and bleomycine (PEB) is considered standard therapy.


📜 SIMILAR VOLUMES


Impact of cytotoxic treatment on long-te
✍ Maria DeSantis; Walter Albrecht; Wolfgang Höltl; Jörg Pont 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 74 KB 👁 2 views

More than half of the patients with testicular germ-cell cancer show impaired spermatogenesis before undergoing cytotoxic treatment. The known pre-treatment infertility and the reversibility of the fertility problems observed in some after successful anti-cancer treatment have so far prevented an as

Treatment outcome of patients with brain
✍ Sophie D. Fosså; Carsten Bokemeyer; Arthur Gerl; Stephane Culine; William G. Jon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Background: Multiinstitutional experience with the management of cerebral metastases from malignant germ cell tumors (mgct) is presented. ## Methods: Clinical data regarding brain metastases from mgct at diagnosis (group 1 [56 patients]) or after cisplatin-based chemotherapy (group 2 [83 patie

Successful treatment of good-risk dissem
✍ Giorgio Pizzocaro; Roberto Salvioni; Fulvio Zanoni; Angelo Milani; Luigi Piva 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB 👁 1 views

Cisplatin, vinblastine and bleomycin (PVB) is very effective therapy in disseminated testicular cancer, but toxicity is severe. A further reduction of vinblastine might reduce the acute toxicity of PVB without compromising the response rate in good-risk patients. Starting in March 1982, 42 consecuti